NCT02045446View on ClinicalTrials.gov

Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 17, 2022

Study Completion Date

May 2, 2022

Conditions

Stage IV Non-Small Cell Lung Cancer

Interventions

RADIATION

Stereotactic Body Radiation Therapy

DRUG

Maintenance chemotherapy

Trial Locations (1)

75235

UT Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER

NCT02045446 - Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial | Biotech Hunter | Biotech Hunter